logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
10/07/2025
Revolut is in negotiations for a new round of funding, with a valuation of $65 billion.
Latest
6 m ago
Guangda Securities research report indicates that the outlook for the oil transportation market in the second half of the year is influenced by two factors: weak demand for crude oil consumption and the unexpected increase in production by OPEC+. It is expected that the disturbance factors in crude oil consumption demand are relatively minor, as current demand is expected to improve marginally with the easing of trade conflicts and the improvement of the macroeconomic situation. The unexpectedly large increase in production by OPEC+ is expected to continue to boost the demand for oil transportation, and the oil transportation market is expected to recover in the second half of 2025. In the long term, with the increase in market share of non-OPEC+ countries, countries such as West Africa, Brazil, the United States, and Norway are expected to continue to increase their demand for oil transportation. Combined with concerns about geopolitical risks in the Middle East, the oil transportation pattern is expected to be reshaped, and the increase in transportation distance is expected to further expand the demand for oil transportation, providing a solid foundation for long-term prosperity in the oil transportation industry.
6 m ago
Guangda Securities: OPEC+ accelerates production increase beyond expectations, the oil transportation market is expected to rebound in the second half of the year.
8 m ago
Asian markets in early trading. Gold rose slightly amid concerns about US tariffs.
8 m ago
Food company WK Kellogg soared over 54% in after-hours trading. Reports stated that Ferrero will acquire the company for $3 billion. Biotechnology company ProKidney also rose nearly 4% after positive results from a clinical trial for a kidney disease drug. The stock has surged over 6 times in the past two trading days.
8 m ago
Cornerstone Pharmaceutical-B(02616.HK): The application for the approval of the registration of the new drug Puxihua (Pirapinib capsules) transferred from overseas to domestic production has been approved by the National Medical Products Administration.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.